Optimized production and concentration of lentiviral vectors containing large inserts
- 29 May 2007
- journal article
- Published by Wiley in The Journal of Gene Medicine
- Vol. 9 (7), 579-584
- https://doi.org/10.1002/jgm.1052
Abstract
Generation of high titer lentiviral stocks and efficient virus concentration are central to maximize the utility of lentiviral technology. Here we evaluate published protocols for lentivirus production on a range of transfer vectors differing in size (7.5–13.2 kb). We present a modified virus production protocol robustly yielding useful titers (up to 107/ml) for a range of different transfer vectors containing packaging inserts up to 7.5 kb. Moreover, we find that virus recovery after concentration by ultracentrifugation depends on the size of the packaged inserts, heavily decreasing for large packaged inserts. We describe a fast (4 h) centrifugation protocol at reduced speed allowing high virus recovery even for large and fragile lentivirus vectors. The protocols outlined in the current report should be useful for many labs interested in producing and concentrating high titer lentiviral stocks. Copyright © 2007 John Wiley & Sons, Ltd.Keywords
This publication has 27 references indexed in Scilit:
- A trans-lentiviral packaging cell line for high-titer conditional self-inactivating HIV-1 vectorsMolecular Therapy, 2006
- Generation of a packaging cell line for prolonged large‐scale production of high‐titer HIV‐1‐based lentiviral vectorThe Journal of Gene Medicine, 2005
- Factors Influencing the Titer and Infectivity of Lentiviral VectorsHuman Gene Therapy, 2004
- Transactivator and Structurally Optimized Inducible Lentiviral VectorsMolecular Therapy, 2004
- Lentiviral and MLV based retroviral vectors for ex vivo and in vivo gene transferMethods, 2004
- Comparison of Transfection Conditions for a Lentivirus Vector Produced in Large VolumesHuman Gene Therapy, 2003
- Doxycycline-regulated lentiviral vector system with a novel reverse transactivator rtTA2S-M2 shows a tight control of gene expression in vitro and in vivoGene Therapy, 2003
- A New-Generation Stable Inducible Packaging Cell Line for Lentiviral VectorsHuman Gene Therapy, 2001
- Generation of a Stable Cell Line Producing High-Titer Self-Inactivating Lentiviral VectorsMolecular Therapy, 2001
- A Stable System for the High-Titer Production of Multiply Attenuated Lentiviral VectorsMolecular Therapy, 2000